Literature DB >> 2019164

Cholesterol: a useful parameter for distinguishing between pleural exudates and transudates.

L Valdés1, A Pose, J Suàrez, J R Gonzalez-Juanatey, A Sarandeses, E San José, J M Alvarez Dobaña, M Salgueiro, J R Rodríguez Suárez.   

Abstract

Previously established criteria were used to classify 253 pleural effusions as transudates (65 cases), neoplastic exudates (67 cases), tuberculous exudates (65 cases), or miscellaneous exudate (56 cases). The parameters pleural LDH (PLDH), pleural LDH/serum LDH ratio (P/SLDH), and pleural protein/serum protein ratio (P/SPROT) were compared with pleural cholesterol (PCHOL) and the pleural cholesterol/serum cholesterol ratio (P/SCHOL) with regard to their usefulness for distinguishing between pleural exudates and transudates. The PCHOL values determined were 28.5 +/- 12.8 mg/dl for transudates, 88.1 +/- 30 mg/dl for neoplastic exudates, 96.5 +/- 28 mg/dl for tuberculous exudates, and 88 +/- 35.9 mg/dl for the miscellaneous group; the differences between the transudate group and the others are statistically significant (p less than 0.001). The sensitivity and specificity of P/SPROT for diagnosis of exudates were both 89 percent; the sensitivity of PLDH was 67 percent and its specificity was 95 percent; the sensitivity and specificity of P/SLDH were both 84.6 percent. Using Light's three criteria as a battery, the sensitivity was 94.6 percent and its specificity was 78.4 percent. All the transudates and 17 (9 percent) of the 188 exudates had PCHOL values below 55 mg/dl, so that with this threshold, PCHOL had a sensitivity of 91 percent and a specificity of 100 percent for diagnosis of exudates. With a threshold of 0.3, P/SCHOL had a sensitivity of 92.5 percent and a specificity of 87.6 percent. The number of misclassifications by PCHOL was less than with any other of the parameters, with statistically significant differences with respect to PLDH (p less than 0.001) and P/SLDH (p less than 0.01). We conclude that determination of PCHOL and P/SCHOL is of great value for distinguishing between pleural exudates and transudates, and should be included in routine laboratory analysis of pleural effusions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2019164     DOI: 10.1378/chest.99.5.1097

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  14 in total

1.  Usefulness of triglyceride levels in pleural fluid.

Authors:  Luis Valdés; Maria Esther San José; Antonio Pose; Juan Carlos Estévez; Francisco J González-Barcala; José M Alvarez-Dobaño; Richard W Light
Journal:  Lung       Date:  2010-10-05       Impact factor: 2.584

Review 2.  Diagnostic tests in pleural effusion--an update.

Authors:  N Berkman; M R Kramer
Journal:  Postgrad Med J       Date:  1993-01       Impact factor: 2.401

3.  Predictive models of malignant transudative pleural effusions.

Authors:  Lucía Ferreiro; Francisco Gude; María E Toubes; Adriana Lama; Juan Suárez-Antelo; Esther San-José; Francisco Javier González-Barcala; Antonio Golpe; José M Álvarez-Dobaño; Carlos Rábade; Nuria Rodríguez-Núñez; Carla Díaz-Louzao; Luis Valdés
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

4.  Diagnostic value of pleural cholesterol in differentiating exudative and transudative pleural effusion.

Authors:  Santosh Gautam; Shiva Raj K C; Binita Bhattarai; Geetika K C; Gauri Adhikari; Purnima Gyawali; Keshab Rijal; Milesh Jung Sijapati
Journal:  Ann Med Surg (Lond)       Date:  2022-09-05

Review 5.  The past, current and future of diagnosis and management of pleural disease.

Authors:  Jason Akulian; David Feller-Kopman
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

6.  Evaluation of serum and pleural levels of angiopoietin-1 and angiopoietin-2 in children with transudative and exudative pleural effusions.

Authors:  Mohammed Sanad; Waheed Shouman; Amal F Gharib
Journal:  Iran J Pediatr       Date:  2011-09       Impact factor: 0.364

7.  The acute-phase proteins serum amyloid A and C reactive protein in transudates and exudates.

Authors:  Alessandra M Okino; Cristiani Bürger; Jefferson R Cardoso; Edson L Lavado; Paulo A Lotufo; Ana Campa
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

8.  The diagnostic role of glycosaminoglycans in pleural effusions: a pilot study.

Authors:  Rozina Vavetsi; Stefanos Bonovas; Paraskevi Polizou; Chrysanthi Papanastasopoulou; Georgia Dougekou; Nikolaos M Sitaras
Journal:  BMC Pulm Med       Date:  2009-02-18       Impact factor: 3.317

9.  Pleural fluid cholesterol in differentiating exudative and transudative pleural effusion.

Authors:  A B Hamal; K N Yogi; N Bam; S K Das; R Karn
Journal:  Pulm Med       Date:  2013-01-10

Review 10.  Can cholesterol be used to distinguish pleural exudates from transudates? evidence from a bivariate meta-analysis.

Authors:  Yongchun Shen; Hong Zhu; Chun Wan; Lei Chen; Tao Wang; Ting Yang; Fuqiang Wen
Journal:  BMC Pulm Med       Date:  2014-04-15       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.